The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research

The utility of TLE1 and BCOR as immunohistochemical markers for angiomatoid fibrous histiocytoma
CONCLUSIONS: TLE1 is a highly sensitive immunohistochemical marker for AFH.PMID:36910892 | PMC:PMC9993016 (Source: International Journal of Clinical and Experimental Pathology)
Source: International Journal of Clinical and Experimental Pathology - March 13, 2023 Category: Pathology Authors: Hui Pan Joshua Byers Hong Yin Heather Rytting Suzanna Logan Mai He Zhongxin Yu Dehua Wang Shamlal Mangray Shengmei Zhou Source Type: research